Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hepatitis C, HIV, Antibiotics And Vaccines Headline Infectious Diseases Discussion At TAP Conference

Nov 28 2011

Related Content

Roche Agrees To Acquire HCV Biotech Anadys For $230 Million

Oct 17 2011

In Advance Of HSV-2 Vaccine Trials, Genocea Taps Investors For $35 Million

Jan 03 2011

Rib-X Teams With Sanofi To Develop Novel, Broad-Spectrum Antibiotics

Jul 06 2011

Sangamo Brushes Off Phase IIb Diabetic Neuropathy Failure

Oct 06 2011

Related Companies

Vertex Pharmaceuticals Incorporated

Merck & Co., Inc.

Pharmasset, Inc.

Gilead Sciences, Inc.

ViroPharma Inc.

Esperion Therapeutics, Inc.

Melinta Therapeutics, Inc.

Sanofi

Trius Therapeutics, Inc.

Genocea Biosciences, Inc.

Anadys Pharmaceuticals, Inc.

Roche Holding AG

Sangamo Therapeutics, Inc.

Chimerix, Inc.

Scynexis, Inc.

Enanta Pharmaceuticals, Inc.

Additional Topics

United States Clinical Trials Deals Platform Technologies BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window